This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Taisho Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toshima-ku, JP (2015)
- Tokyo, JP (2016 - 2021)
Company Filing History:
Years Active: 2015-2026
Title: The Innovative Contributions of Nobutaka Hattori
Introduction
Nobutaka Hattori is a prominent inventor based in Tokyo, Japan, known for his significant contributions in the field of medicinal chemistry. With a total of three patents to his name, Hattori has been at the forefront of developing novel processes and compounds that could potentially address various medical conditions.
Latest Patents
Hattori's latest innovations include a method for producing (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative. This patent presents a novel process that provides a pathway for producing this specific chemical compound, represented by formula (1). Additionally, he has developed an azole derivative that offers therapeutic agents for treating or preventing a wide array of diseases. These include mood disorders, anxiety disorders, schizophrenia, Alzheimer’s disease, Parkinson’s disease, and more. Specifically, his invention presents azole derivatives that possess antagonistic action against the arginine-vasopressin (AVP) V1b receptor, showcasing the potential of his work in addressing significant health challenges.
Career Highlights
Hattori's career is distinguished by his innovative research at Taisho Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work has positioned him as an influential figure in his field, contributing to advancements in treatments for complex medical conditions.
Collaborations
In his endeavor to drive forward pharmaceutical innovations, Nobutaka Hattori collaborates with talented coworkers including Mitsukane Yoshinaga and Takeshi Kuwada. Their collective expertise has aided in the development of groundbreaking advancements in medical treatments, further enhancing the impact of their work within the industry.
Conclusion
Nobutaka Hattori's inventive work continues to push the boundaries of pharmaceutical science. With a focus on creating effective treatments for diseases that affect millions, his contributions are paving the way for future innovations in the healthcare sector. Through his patents and collaborations at Taisho Pharmaceutical Co., Ltd., Hattori demonstrates the powerful intersection of creativity and science in the realm of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile